Go Back
Matrix Partners China
Matrix Partners China, a venture fund established in 1977, operates out of Beijing, China, with a focus on BioTech, Healthcare, AI/ML, Robotics, IoT, and Medical Device sectors. The fund, led by partner Harry Man, has invested in companies like Ansun BioPharma and Trifo. With 653 investments and 43 exits, Matrix Partners China aims to build enduring partnerships with entrepreneurs to create successful enterprises. For more details, visit their website: www.matrixpartners.com.cn.
About
About
About
Bio
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant companies.
Location
Beijing, China
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Harry Man
Bio
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant companies.
Location
Beijing, China
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Harry Man
Fund
Fund
Fund
Fund Focus
BioTech, Healthcare, Medical Device, Artificial Intelligence & Machine Learning (AI/ML), Robotics, IoT (Internet of Things)
Number of investments
653
Number of exits
43
Fund Type
Venture Fund
Portfolio Companies
Ansun BioPharma, Trifo
Matrix Partners China
Matrix Partners China, a venture fund established in 1977, operates out of Beijing, China, with a focus on BioTech, Healthcare, AI/ML, Robotics, IoT, and Medical Device sectors. The fund, led by partner Harry Man, has invested in companies like Ansun BioPharma and Trifo. With 653 investments and 43 exits, Matrix Partners China aims to build enduring partnerships with entrepreneurs to create successful enterprises. For more details, visit their website: www.matrixpartners.com.cn.
About
Bio
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant companies.
Location
Beijing, China
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Harry Man
Fund
Fund Focus
BioTech, Healthcare, Medical Device, Artificial Intelligence & Machine Learning (AI/ML), Robotics, IoT (Internet of Things)
Number of investments
653
Number of exits
43
Fund Type
Venture Fund
Portfolio Companies
Ansun BioPharma, Trifo